Published November 2018 | Version v1
Journal article

Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging

  • 1. School Biomedical Engineering & Imaging Sciences, 4th floor Lambeth Wing, St Thomas' Hospital, King's College London, London SE1 7EH (United Kingdom)
  • 2. Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, London SE 5 8AF (United Kingdom)
  • 3. Department of Molecular Imaging, Sidra Medicine, Doha (Qatar)
  • 4. PET Imaging Centre Facility, King's College London & Guy's and St Thomas NHS Foundation Trust, St Thomas' Hospital, London SE1 7EH (United Kingdom)

Description

The development of clinically useful tracers for PET imaging is enormously challenging and expensive. The intranasal (IN) route of administration is purported to be a viable route for delivering drugs to the brain but has, as yet, not been investigated for the delivery of PET tracers. If the intranasal (IN) pathway presents a viable option, it extends the PET imaging field by increasing the number of tracers available for human use. Here we report the results of a rodent study testing the feasibility of the IN route to administer radiotracers for brain PET imaging.

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2018.08.005;
PII
S0969805118302166;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
66
Journal Page Range
p. 32-39
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2018 The Authors. Published by Elsevier Inc.